• The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke 

      Logallo, Nicola; Kvistad, Christopher Elnan; Nacu, Aliona; Næss, Halvor; Waje-Andreassen, Ulrike; Asmuss, Jörg; Aamodt, Anne Hege; Lund, Christian; Kurz, Martin; Rønning, Ole Morten; Salvesen, Rolf; Idicula, Titto T.; Thomassen, Lars (Peer reviewed; Journal article, 2014-05-15)
      Background: Alteplase is the only approved thrombolytic agent for acute ischaemic stroke. The overall benefit from alteplase is substantial, but some evidence indicates that alteplase also has negative effects on the ...
    • A pragmatic approach to sonothrombolysis in acute ischaemic stroke: The Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS) 

      Nacu, Aliona; Kvistad, Christopher Elnan; Logallo, Nicola; Næss, Halvor; Waje-Andreassen, Ulrike; Aamodt, Anne Hege; Solhoff, Ragnar; Lund, Christian; Tobro, Håkon; Rønning, Ole Morten; Salvesen, Rolf; Idicula, Titto; Thomassen, Lars (Peer reviewed; Journal article, 2015-07-11)
      Background: Ultrasound accelerates thrombolysis with tPA (sonothrombolysis). Ultrasound in the absence of tPA also accelerates clot break-up (sonolysis). Adding intravenous gaseous microbubbles may potentiate the effect ...
    • Stroke unit demand in Norway – present and future estimates 

      Dahl, Fredrik Andreas; Barra, Mathias; Faiz, Kashif Waqar; Ihle-Hansen, Hege; Næss, Halvor; Rand, Kim; Rønning, Ole Morten; Simonsen, Tone Breines; Thommessen, Bente; Labberton, Angela Susan (Journal article; Peer reviewed, 2022-03-15)
      Background: All stroke patients should receive timely admission to a stroke unit (SU). Consequently, most patients with suspected strokes – including stroke mimics (SM) are admitted. The aim of this study was to estimate ...